申请人:JANSSEN PHARMACEUTICA N.V.
公开号:EP0151824A2
公开(公告)日:1985-08-21
Novel N-heterocyclyl-4-piperidinamines of formula
wherein L is a radical of formula
Het-Alk- (b-5); (lower alkenyl)-Y1-Alk- (b-6); or Ar1-Alk-(b-7); the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, which compounds are anti-allergic agents, pharmaceutical compositions containing such compounds as an active ingredient and processes for preparing the said compounds and compositions.
式中的新型 N-杂环基-4-哌啶胺
其中 L 是式中的一个基团
Het-Alk-(b-5);(低级烯基)-Y1-Alk-(b-6);或 Ar1-Alk-(b-7);药学上可接受的酸加成盐及其可能的立体化学异构形式,这些化合物是抗过敏剂,含有此类化合物作为活性成分的药物组合物,以及制备上述化合物和组合物的工艺。